Daunorubicin, doxorubicin and pharmaceutically acceptable salts therefore as anti-retroviral agents
AssigneeMeiji Seika Kaisha, Ltd.
InventorTsuneo Kuramochi
Life of this patent
Estimating the term…
Abstract
Anti-retroviral agents comprising, as active ingredient, an antibiotic of anthracycline family (e.g., daunorubicin and doxorubicin) have higher effect with less toxicity, compared with conventional antiretroviral substances, such as azidothymidine and bleomycin.
Claims3
A method of treating feline leukemia virus cells comprising administering thereto an effective amount of a compound selected from the group consisting of daunorubicin, doxorubicin and pharmaceutically acceptable salts thereof.
A method of inhibiting the production of retrovirus comprising administering thereto an effective amount of a compound selected from the group consisting of daunorubicin, doxorubicin and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.